Purpose: The purpose of this semicontrolled prospective study was to report on the outcomes of 10 Swedish-speaking children treated with the Lidcombe Program and how the parents viewed the treatment.
Method: Ten children at an age from 2:9 to 5:8 (years:months) referred to two clinics for communication disorders were consecutively included in the study. The children had been stuttering for 0:9 to 3:3 with a mean stuttering frequency of 10.1% syllables stuttered (%SS; 0.8-33.9) before treatment. Parents and teachers filled out questionnaires concerning the children's speech and the parents also answered questions on their views on the program.
Results: Eight children completed the program and were reassessed upon completion of the program, about 2 years after progressing to stage 2. There was a significant decrease in mean %SS before and after treatment (7.6 vs. 0.1%, respectively) with a large Cohen effect size (d = 2.9). Parents and teachers found that the treatment had a positive effect on the children's stuttering and all parents would recommend the Lidcombe Program to other families.
Conclusion: The results of this preliminary study suggest that the Lidcombe Program can be an effective treatment for Swedish-speaking preschool children who stutter.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000342149 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Serum concentrations of PFAS across Australian States and Territories.
Int J Hyg Environ Health
April 2025
School of Public Health and Social Work, Faculty of Health, Queensland University of Technology, Kelvin Grove, QLD, 4059, Australia.
Background: Australia's long running human biomonitoring (HBM) program has provided information on per and poly-fluoroalkyl substances (PFAS) serum concentrations in the general population since 2002. The program is based on pooling and analysis of surplus, de-identified, pathology specimens predominantly sourced from Australia's north-eastern state Queensland (QLD). To date, potential nationwide spatial differences across Australia have not been assessed.
View Article and Find Full Text PDFThe Role of Parental Temperament and Parent-Child Fit in Two Stuttering Therapy Programs for Preschool-Aged Children Who Stutter: A Preliminary Study.
J Speech Lang Hear Res
March 2025
Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands.
Purpose: To understand factors contributing to therapy success, this study investigated the role of parents' temperament and the fit between parents' temperament and parent-reported child behavior problems in therapy outcomes across two therapy types.
Method: A total of 177 children who stutter and their parents were included in this study. Data from 149 children were present at the follow-up.
Administering the Lidcombe Program to children who stutter with concomitant disorders: Insights from an exploratory retrospective chart review study.
J Fluency Disord
March 2025
School of Speech-Language Pathology and Audiology, Université de Montréal, Montreal, Quebec, Canada; Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal, Montreal, Quebec, Canada.
Purpose: Children who stutter (CWS) in clinical settings may present with concomitant disorders (CDs), which can complexify the delivery of the Lidcombe Program (LP). However, there is limited evidence on how CDs influence treatment outcomes in CWS, leaving clinicians with little guidance regarding best practices with these children. This exploratory study, conducted in partnership with a rehabilitation center's clinical team, aims to understand which CDs and suspected CDs speech-language pathologists document when treating CWS with the LP and their relationship to treatment characteristics and outcomes.
View Article and Find Full Text PDFImplementing a Hospital-Wide Programme Using iPARiHS to Prevent and Manage Incontinence-Associated Dermatitis and Improve Hospital-Acquired Pressure Injuries.
J Adv Nurs
October 2024
South Western Sydney Nursing and Midwifery Research Alliance, Liverpool, New South Wales, Australia.
Unlabelled: Incontinence-associated dermatitis poses a significant risk for sacral pressure injuries, infection and morbidity in healthcare settings. Despite the availability of best practice guidelines, implementation remains a challenge.
Aim: To outline the implementation of a hospital-wide programme using the Integrated Promoting Action on Research Implementation in Health Services framework to prevent and manage incontinence-associated dermatitis and improve hospital-acquired pressure injuries.
Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study.
Clin Microbiol Infect
December 2024
OUTCOMEREA Research Group, Drancy, France; Institut National de la Santé et de la Recherche Medicale, Infection Antimicrobial Modelisation Evolution, U1137, Team Decision Science in Infectious Diseases, Paris, France; Assistance Publique Hôpitaux de Paris, Bichat hospital, Medical and infectious diseases ICU, F75018, Paris France. Electronic address:
Article Synopsis
- Hospital-acquired bloodstream infections (HA-BSI) in ICU patients can be life-threatening, and this study aimed to see how early adequate antibiotic treatment affects 28-day mortality rates for patients who survive at least one day after infection onset.
- Using data from a multicenter study with 2,418 patients, researchers found that those who received adequate treatment within 24 hours had a lower 28-day mortality rate (32.8%) compared to those who were inadequately treated (40%).
- The study concluded that inadequate antibiotic therapy within 24 hours contributes significantly to 28-day mortality, indicating that quicker treatment could greatly improve patient outcomes in cases of HA-BSI.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!